Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 1;28(suppl_12):xii56-xii73.
doi: 10.1093/annonc/mdx682.

Informatics for cancer immunotherapy

J Hammerbacher  1   2 , A Snyder  3   4
Affiliations
Review

Informatics for cancer immunotherapy

J Hammerbacher et al. Ann Oncol. .

Abstract

The rapid development of immunomodulatory cancer therapies has led to a concurrent increase in the application of informatics techniques to the analysis of tumors, the tumor microenvironment, and measures of systemic immunity. In this review, the use of tumors to gather genetic and expression data will first be explored. Next, techniques to assess tumor immunity are reviewed, including HLA status, predicted neoantigens, immune microenvironment deconvolution, and T-cell receptor sequencing. Attempts to integrate these data are in early stages of development and are discussed in this review. Finally, we review the application of these informatics strategies to therapy development, with a focus on vaccines, adoptive cell transfer, and checkpoint blockade therapies.

Keywords: adoptive cell transfer; bioinformatics; checkpoint blockade; computational biology; immunotherapy; neoantigens.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A sample workflow for informatics in cancer immunotherapy.
Figure 2.
Figure 2.
Quantifying heterogeneity across and within tumors. Simple mutations correspond to single-nucleotide variants and short (e.g. 30 nucleotides) insertions and deletions (i.e. indels); complex mutations include all other genome alterations.
Figure 3.
Figure 3.
Antigen processing and presentation.
Figure 4.
Figure 4.
Local and systemic cancer–immune interactions.
Figure 5.
Figure 5.
Categories of therapeutic interventions in cancer immunotherapy.
See this image and copyright information in PMC

References

    1. Stratton MR, Campbell PJ, Futreal PA.. The cancer genome. Nature 2009; 458(7239): 719–724.http://dx.doi.org/10.1038/nature07943 - DOI - PMC - PubMed
    1. Mardis ER. Genome sequencing and cancer. Curr Opin Genet Dev 2012; 22(3): 245–250.http://dx.doi.org/10.1016/j.gde.2012.03.005 - DOI - PMC - PubMed
    1. Ding L, Wendl MC, McMichael JF, Raphael BJ.. Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet 2014; 15(8): 556–570.http://dx.doi.org/10.1038/nrg3767 - DOI - PMC - PubMed
    1. Martincorena I, Roshan A, Gerstung M. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 2015; 348(6237): 880–886.http://dx.doi.org/10.1126/science.aaa6806 - DOI - PMC - PubMed
    1. Carter SL, Cibulskis K, Helman E. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012; 30(5): 413–421.http://dx.doi.org/10.1038/nbt.2203 - DOI - PMC - PubMed